confirm the burden of atherosclerosis in patients with SLE and support the notion that premature atherosclerosis contributes to cardiovascular disease in this group of patients. The reason for ...

may underestimate CVD risk in SLE." Limitations to the analysis included the small number of cardiovascular events observed during the study and the lack of racial-ethnic diversity among participants.

The past decade has seen the emergence of two new paradigms in inflammatory disease: first, cardiovascular complications of atherosclerosis are markedly increased in patients with rheumatoid ...

Patients with moderate to severe active systemic lupus erythematosus (SLE) who began treatment with anifrolumab in the TULIP-1 and TULIP-2 trials experienced a statistically significant reduction ...

New research suggests the use of oral prednisone should be limited in patients with systemic lupus erythematosus with a history of recurrent pericarditis.

Low neighborhood walkability is associated with increased risk of cardiovascular disease (CVD), according to research ...

Patients with cutaneous lupus erythematosus who used hydroxychloroquine had a significantly reduced risk of developing systemic lupus erythematosus.